Title:
USE OF BENZOTHIENO-2,3-D-PYRIMIDINES WITH PDE V INHIBITORY EFFECT FOR THE TREATMENT OF ERECTILE DYSFUNCTION
Document Type and Number:
WIPO Patent Application WO2001064192
Kind Code:
A3
Abstract:
The invention relates to the use of a highly penis-specific PDE V inhibitor, or a physiologically acceptable salt or solvate thereof, for the production of a medicament for the treatment of erectile dysfunction in males, without the previous circulatory side effects caused by PDE V inhibitors, in particular, with concomitant administration of vasodilators, whose mode of action is by means of the NO/cGMP system.
Inventors:
BRAENDLE MARIAN (DE)
EHRING THOMAS (DE)
WILM CLAUDIA (DE)
EHRING THOMAS (DE)
WILM CLAUDIA (DE)
Application Number:
PCT/EP2001/001557
Publication Date:
December 20, 2001
Filing Date:
February 13, 2001
Export Citation:
Assignee:
MERCK PATENT GMBH (DE)
BRAENDLE MARIAN (DE)
EHRING THOMAS (DE)
WILM CLAUDIA (DE)
BRAENDLE MARIAN (DE)
EHRING THOMAS (DE)
WILM CLAUDIA (DE)
International Classes:
A61K31/00; C07D495/04; A61K31/519; A61K45/06; A61P15/00; A61P15/10; (IPC1-7): A61K31/505
Domestic Patent References:
| WO1998053819A1 | 1998-12-03 | |||
| WO1999066924A1 | 1999-12-29 | |||
| WO2000010542A2 | 2000-03-02 | |||
| WO2000066099A2 | 2000-11-09 | |||
| WO1999055708A1 | 1999-11-04 | |||
| WO2000078767A1 | 2000-12-28 |
Download PDF:
Previous Patent: BODIES FOR THE CONTROLLED RELEASE OF ACTIVE SUBSTANCES
Next Patent: EXEMESTANE FOR FIRST-LINE TREATMENT OF BREAST CANCER
Next Patent: EXEMESTANE FOR FIRST-LINE TREATMENT OF BREAST CANCER